Thyroid Gland Papillary Carcinoma — Trials

Thyroid Gland Papillary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 29
Recruiting: 13
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: Cancer Research UK
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 151–158 of 158 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00095693	Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer	terminated	Phase 2	25	National Cancer Institute (NCI)NIH	1	Jan 16, 2014	clinicaltrials
NCT01100619	A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors	completed	Phase 1	40	ExelixisINDUSTRY	1	Sep 19, 2013	clinicaltrials